Warning: Last items in stock!
Sorafenib is a kinase inhibitor indicated for the treatment of
1. Unresectable hepatocellular carcinoma
2. Advanced renal cell carcinoma
3. Locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment.
|Warnings||Don't take the drug without consulting a qualified doctor or physician.|
|Suggested use||Follow the doctor's advice|
|Delivery & Returns||10-20 days|